Latest filing published 10 Jun 2024 for Soleno Therapeutics INC. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Ernest Mario, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Soleno Therapeutics Inc, Chimerix Inc and Celgene Corp /DE/. In total, 13 filings cover trades dated from 13 January 2016 to 6 June 2024.
Purchases make up the whole of the open-market record (1 purchase). The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 7 share grants and 3 option exercises.
Most recently, on 10 June 2024, the filings show a share grant in Soleno Therapeutics Inc. The clock since the last published purchase (4 April 2022) now reads 1,658 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations